TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
BioNema AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
3,879
|
3,237
|
2,545 |
| Financial expenses |
2
|
2
|
5 |
| Earnings before taxes |
1,149
|
314
|
328 |
| EBITDA |
1,208
|
376
|
424 |
| Total assets |
3,156
|
2,441
|
2,275 |
| Current assets |
1,305
|
2,008
|
1,808 |
| Current liabilities |
313
|
306
|
194 |
| Equity capital |
2,843
|
2,135
|
2,081 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
90.1%
|
87.5%
|
91.5% |
| Turnover per employee |
1,940
|
1,618
|
1,272 |
| Profit as a percentage of turnover |
29.6%
|
9.7%
|
12.9% |
| Return on assets (ROA) |
36.5%
|
12.9%
|
14.6% |
| Current ratio |
416.9%
|
656.2%
|
932.0% |
| Return on equity (ROE) |
40.4%
|
14.7%
|
15.8% |
| Change turnover |
642
|
692
|
-936 |
| Change turnover % |
20%
|
27%
|
-27% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.